Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MDC-Verte Fund is a collaboration between MDC-Studio and the Verte Opportunity Zone Fund, established to support early-stage medical technology companies. Based in Baltimore, Maryland, the fund focuses on innovators in Opportunity Zones across the United States. It provides capital to bridge the gap between personal funding and traditional later-stage investments.
The fund primarily invests in early-stage medical technology companies, particularly those located in Opportunity Zones. Investment areas include medical devices for surgery and trauma care, wearable technologies for diagnostics, and robotic technologies for rehabilitation. Typical stages include pre-seed, seed, and seed+ (extension) rounds.
Notable portfolio companies include Modular Matter, which develops advanced prostheses and braces using metamaterials, and Aerea Medical, co-founded by Dr. Aldo Iacono, focused on tools for managing respiratory diseases.
Email info@mdc-verte.com with your deck to pitch MDC-Verte Fund.
MDC-Verte Fund often leads rounds for early-stage medical technology companies, particularly in Opportunity Zones.
The fund is open to follow-on investments, especially for companies that demonstrate significant progress and potential in their respective fields.
Specific details about the fund size are not disclosed, but it is designed to support multiple early-stage investments in medical technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.